Steris (STE) EPS (Weighted Average and Diluted) (2018 - 2026)

Steris' EPS (Weighted Average and Diluted) history runs 9 years deep, the most recent figure standing at $2.24 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) rose 47.37% year-over-year to $2.24; the TTM figure through Mar 2026 stood at $7.93 (up 28.11% YoY), while the FY2026 annual figure was $7.93, up 27.9% from the prior year.
• EPS (Weighted Average and Diluted) was $2.24 for Q1 2026 at Steris, up from $1.96 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2.24 in Q1 2026 to a low of -$0.01 in Q1 2024.
• Historically, EPS (Weighted Average and Diluted) has averaged $1.42 across 5 years, with a median of $1.42 in 2023.
• The sharpest annual moves came in 2024 and 2025: EPS (Weighted Average and Diluted) sank 100.53% in 2024, then surged 15300.0% in 2025.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $1.24 in 2022, then advanced by 14.52% to $1.42 in 2023, then grew by 23.24% to $1.75 in 2024, then increased by 12.0% to $1.96 in 2025, then increased by 14.29% to $2.24 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $2.24 (Q1 2026), $1.96 (Q4 2025), and $1.94 (Q3 2025), per Business Quant data.